Cargando…

Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study

OBJECTIVE: We previously established a gross tissue response (GTR) system to evaluate the intraoperative response of perigastric tissue in patients with gastric cancers to neoadjuvant chemotherapy. This prospective cohort study aims to confirm the relationship between gross tissue response and clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hua, Zhang, Wei-Han, Ge, Rui, Peng, Bo-Qiang, Chen, Xin-Zu, Yang, Kun, Liu, Kai, Chen, Xiao-Long, He, Du, Liu, Jian-Ping, Zhang, Wei-Wei, Qin, Yun, Zhou, Zong-Guang, Hu, Jian-Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651877/ https://www.ncbi.nlm.nih.gov/pubmed/34900661 http://dx.doi.org/10.3389/fonc.2021.585006

Ejemplares similares

Safety and Efficacy of Laparoscopic Versus Open Gastrectomy in Patients With Advanced Gastric Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis
por: Liao, Xu-Liang, et al.
Publicado: (2021)

Difference Between Signet Ring Cell Gastric Cancers and Non-Signet Ring Cell Gastric Cancers: A Systematic Review and Meta-Analysis
por: Zhang, Chi, et al.
Publicado: (2021)

Prognostic Value of Changes in Preoperative and Postoperative Serum CA19-9 Levels in Gastric Cancer
por: Song, Xiao-Hai, et al.
Publicado: (2020)

Nomogram to Predict Intensive Care Following Gastrectomy for Gastric Cancer: A Useful Clinical Tool to Guide the Decision-Making of Intensive Care Unit Admission
por: Pan, Tao, et al.
Publicado: (2022)

Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis
por: Ling, Qi, et al.
Publicado: (2023)

The Survival Benefit and Safety of Splenectomy for Gastric Cancer With Total Gastrectomy: Updated Results(†)
por: Yang, Kun, et al.
Publicado: (2021)

Impact of Type of Postoperative Complications on Long-Term Survival of Gastric Cancer Patients: Results From a High-Volume Institution in China
por: Pang, Hua-Yang, et al.
Publicado: (2021)

The Significance of the CLDN18-ARHGAP Fusion Gene in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Wei-Han, et al.
Publicado: (2020)

Laparoscopic infrapyloric lymph nodes dissection through the right bursa omentalis approach for gastric cancer
por: Yang, Kun, et al.
Publicado: (2021)

The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Ge, Rui, et al.
Publicado: (2022)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
por: Xie, Jian-Wei, et al.
Publicado: (2021)

The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells
por: Sun, Li-Fei, et al.
Publicado: (2020)

Comparison of quality of life between Billroth-І and Roux-en-Y anastomosis after distal gastrectomy for gastric cancer: A randomized controlled trial
por: Yang, Kun, et al.
Publicado: (2017)

The Value of Palliative Gastrectomy for Gastric Cancer Patients With Intraoperatively Proven Peritoneal Seeding
por: Yang, Kun, et al.
Publicado: (2015)

The survival benefit and safety of No. 12a lymphadenectomy for gastric cancer patients with distal or total gastrectomy
por: Yang, Kun, et al.
Publicado: (2016)

Superiority of Tumor Location-Modified Lauren Classification System for Gastric Cancer: A Multi-Institutional Validation Analysis
por: Zhao, Lin-Yong, et al.
Publicado: (2018)

Author Correction: Comparison of quality of life between Billroth-І and Roux-en-Y anastomosis after distal gastrectomy for gastric cancer: A randomized controlled trial
por: Yang, Kun, et al.
Publicado: (2018)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
por: Sun, Juan, et al.
Publicado: (2021)

Levels of oxidative stress in patients with neoadjuvant chemotherapy for gastric cancer: correlation with treatment response
por: Lu, Jiatong, et al.
Publicado: (2023)

A Machine Learning Model for Predicting a Major Response to Neoadjuvant Chemotherapy in Advanced Gastric Cancer
por: Chen, Yonghe, et al.
Publicado: (2021)

Neoadjuvant Anlotinib and chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced esophageal squamous cell carcinoma: Short-term results of an open-label, randomized, phase II trial
por: Wang, Ying-Jian, et al.
Publicado: (2022)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis
por: Wang, Jincheng, et al.
Publicado: (2022)

Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China
por: Zhang, Wei-Han, et al.
Publicado: (2015)

Comparisons Between Different Procedures of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy
por: Yang, Kun, et al.
Publicado: (2015)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

Characteristics and survival outcomes related to the infra-pyloric lymph node status of gastric cancer patients
por: Zhang, Wei-Han, et al.
Publicado: (2018)

Closure of Petersen’s defect in gastrectomy for gastric cancer: an interrupted time series analysis from a high-volume institution in China
por: Pan, Tao, et al.
Publicado: (2020)

Survival Benefit and Safety of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy
por: Yang, Kun, et al.
Publicado: (2014)

Prognostic Value of Metastatic No.8p LNs in Patients with Gastric Cancer
por: Guo, Dong-Jiao, et al.
Publicado: (2015)

CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Yong, et al.
Publicado: (2022)

Gross Tumor Volume Predicts Survival and Pathological Complete Response of Locally Advanced Esophageal Cancer After Neoadjuvant Chemoradiotherapy
por: Wang, Rong, et al.
Publicado: (2022)

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yinkui, et al.
Publicado: (2020)

Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China
por: Song, Xiao-Hai, et al.
Publicado: (2020)

Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study
por: Wang, Xin, et al.
Publicado: (2022)

Robot-Assisted versus Laparoscopic-Assisted Gastrectomy among Gastric Cancer Patients: A Retrospective Short-Term Analysis from a Single Institution in China
por: Sun, Li-Fei, et al.
Publicado: (2019)

Associations between serum CA724 and HER2 overexpression among stage II–III resectable gastric cancer patients: an observational study
por: Chen, Xin-Zu, et al.
Publicado: (2016)

Prognostic Significance of Tumor Size in 2405 Patients With Gastric Cancer: A Retrospective Cohort Study
por: Zhao, Lin-Yong, et al.
Publicado: (2015)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
por: Wan, Xiang-Bo, et al.
Publicado: (2020)

Meta-Analysis of Shrinkage Mode After Neoadjuvant Chemotherapy for Breast Cancers: Association With Hormonal Receptor
por: Zheng, Chun-Hui, et al.
Publicado: (2022)

Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study
por: Xie, Kun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gngakgb2okjoc3e1qgc2kp9m12